Carbocisteine: Difference between revisions
Rabin Bista (talk | contribs) No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (5 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
: [[File:Carbocystiene Wiki Str.png|right|300px]] | |||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
| | |||
| | |||
'''Carbocisteine''' is a [[mucolytic]] that reduces the viscosity of sputum and so can be used to help relieve the symptoms of [[chronic obstructive pulmonary disorder]] (COPD) and [[bronchiectasis]] by allowing the sufferer to bring up [[sputum]] more easily. Carbocisteine should not be used with [[antitussive]]s (cough suppressants) or medicines that dry up bronchial secretions. | '''Carbocisteine''' is a [[mucolytic]] that reduces the viscosity of sputum and so can be used to help relieve the symptoms of [[chronic obstructive pulmonary disorder]] (COPD) and [[bronchiectasis]] by allowing the sufferer to bring up [[sputum]] more easily. Carbocisteine should not be used with [[antitussive]]s (cough suppressants) or medicines that dry up bronchial secretions. | ||
| Line 87: | Line 17: | ||
==References== | ==References== | ||
{{reflist|2}} | |||
{{Cough and cold preparations}} | {{Cough and cold preparations}} | ||
[[Category:Drug]] | |||
[[Category:Dicarboxylic acids]] | [[Category:Dicarboxylic acids]] | ||
[[Category:Expectorants]] | [[Category:Expectorants]] | ||
[[Category:Thioethers]] | [[Category:Thioethers]] | ||
[[Category:Amino acid derivatives]] | [[Category:Amino acid derivatives]] | ||
Latest revision as of 16:15, 8 April 2015
|
WikiDoc Resources for Carbocisteine |
|
Articles |
|---|
|
Most recent articles on Carbocisteine Most cited articles on Carbocisteine |
|
Media |
|
Powerpoint slides on Carbocisteine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Carbocisteine at Clinical Trials.gov Trial results on Carbocisteine Clinical Trials on Carbocisteine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Carbocisteine NICE Guidance on Carbocisteine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Carbocisteine Discussion groups on Carbocisteine Patient Handouts on Carbocisteine Directions to Hospitals Treating Carbocisteine Risk calculators and risk factors for Carbocisteine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Carbocisteine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Carbocisteine is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
Carbocisteine is produced by alkylation of cysteine with chloroacetic acid.[1]
Trade names
- Fluidol, Humotusin: Romania
- Rhinathiol: Bulgaria, Congo, Hong Kong, Hungary, Latvia, Lithuania, Malaysia, Oman, Romania, Singapore, South Korea, Switzerland, Taiwan, Thailand, Tunisia, and Vietnam[2]
- Mucodyne: United Kingdom, India, Ireland, Japan, Netherlands, Serbia.
- Mucoral: Portugal
- Mucosol: Egypt
- Solmux, Loviscol: Philippines
References
- ↑ Karlheinz Drauz, Ian Grayson, Axel Kleemann, Hans-Peter Krimmer, Wolfgang Leuchtenberger, Christoph Weckbecker “Amino Acids” in Ullmann's Encyclopedia of Industrial Chemistry, 2007, Wiley-VCH, Weinheim. doi:10.1002/14356007.a02_057.pub2
- ↑ http://www.drugs.com/international/rhinathiol.html